The company is making its online staffing platform available to people seeking jobs as physical therapists, surgical techs and other allied health professions.
Medtronic developed a way to reduce false alerts through its AccuRhythm™ AI algorithms. The algorithm is applied through cloud-based updates to all LINQ II™ Insertable Cardiac Monitors (ICMs) and helps improve the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms.
To learn more about AccuRhythm AIPlatform, please click here to download an infographic explaining how it works.
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. Don't miss your chance to save with the Super Early Bird Rate.
By Stephanie Baum Wednesday, June 29, 2022 7:54 AM
Dr. Mona Flores, Global Head of Medical AI at Nvidia, will deliver the keynote talk kicking off the MedCity INVEST Digital Health conference, scheduled for Wednesday, September 28, in Dallas and presented in collaboration with Health Wildcatters. Register today.
By Stephanie Baum Wednesday, June 29, 2022 7:30 AM
As life science companies seek to boost clinical trial participation, eConsent forms can pose a stumbling block. A white paper by Medable shares some insights on how companies can leverage eConsent to improve clinical trial recruitment and retention.
Astellas Pharma has a new partner in the R&D of a type of cancer drug called an antibody drug conjugate (ADC). The Japanese pharma company reached across the Pacific Ocean to collaborate with Sutro Biopharma in a bet that Bay Area-based firm's technology can deliver more powerful ADCs.
Obese patients are more at risk for diabetes, cardiovascular disease, certain cancers and mortality than patients who maintain a healthy weight, and obese patient who develop these chronic conditions usually have more complications. That is why providers and payers must integrate more weight loss strategies in chronic condition care, panelists argued at a Tuesday panel hosted by the Chamber of Commerce.
Socially Determined, a healthcare analytics startup focused on social determinants of health insights, closed a $26 million funding round on Tuesday. It will used the funds to expand its customer base, which comprises health plans, health systems and life sciences organizations.
By Arundhati Parmar Tuesday, June 28, 2022 2:44 PM
In a wide-ranging discussion, Amwell Chairman & CEO Ido Schoenberg expressed frustration at being lumped together with other telehealth companies that have very different approaches and business models. But he was also very optimistic about the category overall.
Sanofi won European Commission approval for two therapies that treat rare enzyme deficiencies. Xenpoyzme is the first treatment for acid sphingomyelinase deficiency (ASMD) while Nexviadyme is a successor to a blockbuster Sanofi drug for Pompe disease.
A webinar sponsored by Carta Healthcare, scheduled for Wednesday, July 20, will highlight the role of AI in mining patient data and ways to improve it.
In this free webinar, industry experts from Syneos and Medable will share their perspectives on how to address these drug development challenges within cardiometabolic clinical studies and provide input on the impact of new regulatory guidance such as the DEPICT Act. This engaging panel will discuss leveraging technology and home health solutions to augment existing points of care between patients and their clinical care team to improve the patient experience, drive more scientific rigor to data generation and achieve timely endpoint capture.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments